pharmaphorum

AUGUST 4, 2021

The HDAC inhibitor was given an accelerated approval by the FDA as a second-line PTCL therapy on the strength of overall response data, but a phase 3 study comparing Istodax to first-line chemotherapy showed no improvement on progression-free survival (PFS).

FDA 98

FDA Chemotherapy Labelling 98

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. Benefits of daily oral chemotherapy over IV.

Chemotherapy 104

Chemotherapy Dosage Labelling Compounding 104

pharmaphorum

MARCH 8, 2021

AZ is seeking to use Lynparza in patients who had also been previously treated with the chemotherapy drug docetaxel, but NICE has concluded that the application failed to provide evidence of the PARP inhibitor’s value compared to standard therapy.

Chemotherapy 98

Chemotherapy Labelling FDA 98

The Checkup by Singlecare

AUGUST 24, 2023

In a 2014 analysis of 25 clinical trials, researchers found that probiotics such as acidophilus can also help treat moderate to severe eczema symptoms in adults. In one 2010 study , 112 pregnant women with a familial history of allergies were given either a daily probiotic or a placebo pill. Is acidophilus safe for everyone?

Immunization 98

Immunization Pharmacy Program Director Chemotherapy Dosage 98

The Checkup by Singlecare

DECEMBER 13, 2023

Antiemetics may also reduce radiation-associated or chemotherapy-induced nausea resulting from cancer treatment. Be sure to follow the dosing instructions on the label for your child’s age. Antiemetic side effects Most OTC antiemetics are well-tolerated and safe if taken according to the labeled instructions.

Dosage 97

Dosage Labelling Chemotherapy Immunization 97

pharmaphorum

DECEMBER 14, 2022

Amgen’s Blincyto (blinatumomab) was the first bispecific T cell engager to be approved for marketing way back in 2014, but has been a slow burner product for Amgen, with sales rising slowly to $472 million last year in its main indication in B-cell acute lymphoblastic leukaemia (B-ALL). years’ follow-up. years’ follow-up.

Mayo Clinic 52

Mayo Clinic Chemotherapy Labelling Hospitals 52

The Thyroid Pharmacist

SEPTEMBER 1, 2023

They include anesthetics, antacids, anti-anxiety medications, antibiotics, antidepressants, antifungals, cholesterol-lowering medications, anti-malarial medications, chemotherapy, appetite suppressants, arthritis medications, psychotropics, and steroids. Published 2014 Jan 3. Published 2014 Jan 3. Springerplus. Springerplus.

Compounding 116

Compounding Adverse Reactions Chemotherapy Labelling 116